116 related articles for article (PubMed ID: 2507819)
1. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
Tsukamura M
Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
[TBL] [Abstract][Full Text] [Related]
2. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex].
Tsukamura M
Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509
[TBL] [Abstract][Full Text] [Related]
3. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex].
Tsukamura M
Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652
[TBL] [Abstract][Full Text] [Related]
4. [In-vitro combined effect of antituberculosis drugs on Mycobacterium avium complex].
Tsukamura M; Yamori S
Kekkaku; 1990 Apr; 65(4):257-62. PubMed ID: 2376931
[TBL] [Abstract][Full Text] [Related]
5. [Bactericidal activity of antituberculosis drugs against Mycobacterium avium complex].
Tsukamura M
Kekkaku; 1990 Jan; 65(1):9-12. PubMed ID: 2313966
[TBL] [Abstract][Full Text] [Related]
6. [Interrelationship among colonial morphology, susceptibility to antituberculosis drugs, growth rate, and viability in Dubos liquid medium in Mycobacterium avium complex strains].
Tsukamura M
Kekkaku; 1989 Dec; 64(12):753-9. PubMed ID: 2615130
[TBL] [Abstract][Full Text] [Related]
7. [In-vitro susceptibility of Mycobacterium avium complex to isoniazid and ethionamide].
Tsukamura M; Yamori S
Kekkaku; 1990 Mar; 65(3):243-7. PubMed ID: 2352411
[TBL] [Abstract][Full Text] [Related]
8. [Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains].
Tsukamura M; Yamori S
Kekkaku; 1990 Aug; 65(8):519-25. PubMed ID: 2214513
[TBL] [Abstract][Full Text] [Related]
9. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
Tsukamura M
Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
[TBL] [Abstract][Full Text] [Related]
10. [Resistance testing of M. avium-intracellulare and M. tuberculosis of AIDS patients with new drugs and drug combinations].
Mauch H; Reichert B; Ruf B; Brehmer W
Pneumologie; 1990 Feb; 44 Suppl 1():504-6. PubMed ID: 2114636
[TBL] [Abstract][Full Text] [Related]
11. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
12. [Cross-resistance relationship between streptomycin and kanamycin resistances in Mycobacterium smegmatis (strain Jucho)--comparison of the development patterns of resistances to streptomycin and kanamycin among Mycobacterium tuberculosis, Mycobacterium avium complex, and Mycobacterium smegmatis].
Tsukamura M
Kekkaku; 1990 Dec; 65(12):785-9. PubMed ID: 2127614
[TBL] [Abstract][Full Text] [Related]
13. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
14. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
15. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
Tsukamura M
Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
[TBL] [Abstract][Full Text] [Related]
17. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 May; 68(5):367-70. PubMed ID: 8331881
[TBL] [Abstract][Full Text] [Related]
19. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex].
Yamamoto T; Amitani R; Kuze F; Suzuki K
Kekkaku; 1990 Dec; 65(12):805-10. PubMed ID: 2127615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
